Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma

Abstract

Minichromosome maintenance protein 6 (MCM6) is one of six proteins of the MCM family which are involved in the initiation of DNA replication and thus represent a marker of proliferating cells. Since the level of cell proliferation is the most valuable predictor of survival in mantle cell lymphoma (MCL), we investigated lymph node biopsy specimens from 70 patients immunohistochemically with a monoclonal antibody against MCM6. The percentage of MCM6 expressing lymphoma cells ranged from 12.0 to 95.6%, with a mean of 61.0%, and was significantly higher than the percentage of Ki-67-positive cells (P<0.0001). Surprisingly, the ratio of MCM6-positive cells to Ki-67-positive cells was higher than in normal stimulated peripheral blood mononuclear cells, indicating a cell early G1-phase arrest in MCL. A high MCM6 expression level of more than 75% positive cells was associated with a significantly shorter overall survival time (16 months) compared to MCL with a low MCM6 expression level of less than 25% (no median reached, P<0.0001). Multivariate analysis revealed MCM6 to be an independent predictor of survival that is superior to the international prognostic factor and the Ki-67 index. Therefore, aside from gene expression profiling, immunohistochemical detection of MCM6 seems to be the most promising marker for predicting the outcome in MCL.

DOI: 10.1038/sj.bjc.6602795

Extracted Key Phrases

8 Figures and Tables

Statistics

0200400600'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

1,388 Citations

Semantic Scholar estimates that this publication has 1,388 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Schrader2005MinichromosomeMP, title={Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma}, author={Carsten Schrader and Dirk Janssen and Wolfram Klapper and J-U Siebmann and Peter J. Meusers and Guenter Brittinger and Michael Kneba and Markus Tiemann and Reza M. Parwaresch}, journal={British Journal of Cancer}, year={2005}, volume={93}, pages={939 - 945} }